Cannara Biotech Stock Profit Margin
| LOVE Stock | CAD 1.09 0.02 1.87% |
Cannara Biotech fundamentals help investors to digest information that contributes to Cannara Biotech's financial success or failures. It also enables traders to predict the movement of Cannara Stock. The fundamental analysis module provides a way to measure Cannara Biotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cannara Biotech stock.
Cannara |
Cannara Biotech Company Profit Margin Analysis
Cannara Biotech's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Cannara Biotech Profit Margin | 0.07 % |
Most of Cannara Biotech's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cannara Biotech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Cannara Biotech has a Profit Margin of 0.0693%. This is 100.62% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The profit margin for all Canada stocks is 105.46% lower than that of the firm.
Cannara Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cannara Biotech's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cannara Biotech could also be used in its relative valuation, which is a method of valuing Cannara Biotech by comparing valuation metrics of similar companies.Cannara Biotech is currently under evaluation in profit margin category among its peers.
Cannara Fundamentals
| Return On Equity | 0.0678 | ||||
| Return On Asset | 0.0378 | ||||
| Profit Margin | 0.07 % | ||||
| Operating Margin | 0.08 % | ||||
| Current Valuation | 135.7 M | ||||
| Shares Outstanding | 90.64 M | ||||
| Shares Owned By Insiders | 49.42 % | ||||
| Number Of Shares Shorted | 10 | ||||
| Price To Book | 1.07 X | ||||
| Price To Sales | 1.26 X | ||||
| Revenue | 81.75 M | ||||
| Gross Profit | 28.88 M | ||||
| EBITDA | 14.29 M | ||||
| Net Income | 6.44 M | ||||
| Cash And Equivalents | 5.56 M | ||||
| Cash Per Share | 0.01 X | ||||
| Total Debt | 9.23 M | ||||
| Debt To Equity | 0.45 % | ||||
| Current Ratio | 2.95 X | ||||
| Book Value Per Share | 0.91 X | ||||
| Cash Flow From Operations | 10.68 M | ||||
| Short Ratio | 0.03 X | ||||
| Earnings Per Share | 0.08 X | ||||
| Number Of Employees | 10 | ||||
| Beta | 1.07 | ||||
| Market Capitalization | 96.99 M | ||||
| Total Asset | 154.72 M | ||||
| Retained Earnings | (12.9 M) | ||||
| Working Capital | 40.47 M | ||||
| Net Asset | 154.72 M |
About Cannara Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cannara Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cannara Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cannara Biotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Cannara Stock Analysis
When running Cannara Biotech's price analysis, check to measure Cannara Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cannara Biotech is operating at the current time. Most of Cannara Biotech's value examination focuses on studying past and present price action to predict the probability of Cannara Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cannara Biotech's price. Additionally, you may evaluate how the addition of Cannara Biotech to your portfolios can decrease your overall portfolio volatility.